CCCC(=O)N1c2nc(C(C)C)nn2C2(CCCCC2)[C@@H]2CCCC[C@@H]21
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?